An audit of conjunctival melanoma treatment in Liverpool

Eye

Volumn 23, Issue 4, 2009, Pages 801-809

  Damato, B ^a   Coupland, S E ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Conjunctival neoplasms; Disease specific mortality; Melanoma; Ophthalmology; Pathology; Treatment

Indexed keywords

MITOMYCIN C;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; CONTROLLED STUDY; CRYOTHERAPY; HUMAN; MELANOMA; SALVAGE THERAPY; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BRACHYTHERAPY; CLINICAL AUDIT; CONJUNCTIVAL NEOPLASMS; CRYOTHERAPY; ENGLAND; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; VISUAL ACUITY; YOUNG ADULT;

EID: 65349196190     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.154     Document Type: Article

References (37)

1. Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998; 42: 321-350.
2. Damato B, Coupland SE. Clinical mapping of conjunctival melanomas. Br J Ophthalmol 2007.
3. Reese AB. Precancerous and cancerous melanosis. Am J Ophthalmol 1966; 61: 1272-1277.
4. Paridaens AD, McCartney AC, Minassian DC, Hungerford JL. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol 1994; 78: 520-528.
5. Treacher Collins E. Case of epibulbar sarcoma cured by its removal and the application of radium. Trans Ophthal Soc UK 1918; 38: 125-127.
6. Lederman M, Wybar K, Busby E. Malignant epibulbar melanoma: natural history and treatment by radiotherapy. Br J Ophthalmol 1984; 68: 605-617.
7. Lommatzsch PK, Lommatzsch RE, Kirsch I, Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol 1990; 74: 615-619.
8. Zografos L, Uffer S, Bercher L, Gailloud C. Combined surgery, cryocoagulation and radiotherapy for treatment of melanoma of the conjunctiva. Klin Monatsbl Augenheilkd 1994; 204: 385-390.
9. Stannard CE, Sealy GR, Hering ER, Pereira SB, Knowles R, Hill JC. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy. Ophthalmology 2000; 107: 951-958.
10. Desjardins L, Poncet P, Levy C, Schlienger P, Asselain B, Validire P. Prognostic factors in malignant melanoma of the conjunctiva. An anatomo-clinical study of 56 patients. J Fr Ophtalmol 1999; 22: 315-321.
11. Steinkogler FJ, Binder W, Seitz W. Technique of ruthenium- 106 application in the treatment of conjunctival melanoma. Strahlentherapie Onkol 1987; 163: 787-790.
12. Lommatzsch PK. Beta-Ray treatment of malignant epibulbar melanoma. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1978; 209: 111-124.
13. Wuestemeyer H, Sauerwein W, Meller D, Chauvel P, Schueler A, Steuhl KP et al. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol 2005; 244: 1-9.
14. Jakobiec FA, Rini FJ, Fraunfelder FT, Brownstein S. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases. Ophthalmology 1988; 95: 1058-1070.
15. Shields CL, Shields JA, Gunduz K, Cater J, Mercado GV, Gross N et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000; 118: 1497-1507.
16. Finger PT. 'Finger-tip' cryotherapy probes: treatment of squamous and melanocytic conjunctival neoplasia. Br J Ophthalmol 2005; 89: 942-945.
17. Snell S. A case of naevus of the plica semilunaris and two other cases of naevus of the conjunctiva. Trans Ophthal Soc UK 1893; 13: 39-44.
18. Finger PT, Milner MS, McCormick SA. Topical chemotherapy for conjunctival melanoma. Br J Ophthalmol 1993; 77: 751-753.
19. Frucht-Pery J, Pe'er J. Use of Mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia. Arch Ophthalmol 1996; 114: 1261-1264.
20. Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol 2002; 86: 163-167.
21. Missotten GS, Keijser S, de Keizer RJ, Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci 2005; 46: 75-82.
22. Tuomaalä S, Kivelä T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 2004; 111: 816-821.
23. Paridaens AD, Minassian DC, McCartney AC, Hungerford JL. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol 1994; 78: 252-259.
24. Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 1989; 96: 147-166.
25. Tuomaala S, Eskelin S, Tarkkanen A, Kivelä T. Populationbased assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci 2002; 43: 3399-3408.
26. Folberg R, McLean IW. Primary acquired melanosis and melanoma of the conjunctiva: terminology, classification, and biologic behavior. Hum Pathol 1986; 17: 652-654.
27. Stefani FH. A prognostic index for patients with malignant melanoma of the conjunctiva. Graefes Arch Clin Exp Ophthalmol 1986; 224: 580-582.
28. TNM Classification of Malignant Tumours, 6th ed. Wiley-Liss: New York 2002; 215-217.
29. Nijhawan N, Ross MI, Diba R, Ahmadi MA, Esmaeli B et al. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg 2004; 20: 291-295.
30. Lommatzsch PK,Werschnik C, Gutz U. Intraocular invasion of melanoma of the conjunctiva. Klin Monatsbl Augenheilkd 1999; 215: 370-372.
31. Sandinha T, Russell H, Kemp E, Roberts F. Malignant melanoma of the conjunctiva with intraocular extension: a clinicopathological study of three cases. Graefes Arch Clin Exp Ophthalmol 2007; 245: 431-436.
32. Norregaard JC, Gerner N, Jensen OA, Prause JU. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 1996; 234: 569-572.
33. Paridaens D, Beekhuis H, van den BW, Remeyer L, Melles G et al. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br J Ophthalmol 2001; 85: 658-661.
34. Gündüz K, Uçakhan OO, Kanpolat A, Gü nalp I. Nonpreserved human amniotic membrane transplantation for conjunctival reconstruction after excision of extensive ocular surface neoplasia. Eye 2006; 20: 351-357.
35. Lommatzsch PK, Werschnik C. Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up. Klin Monatsbl Augenheilkd 2002; 219: 710-721.
36. Shields JA, Shields CL, Mashayekhi A, Marr BP, Benavides R, Thangappan A et al. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture. Ophthalmology 2008; 115: 511-519.
37. Tuomaala S, Aine E, Saari KM, Kivelä T. Corneally displaced malignant conjunctival melanomas. Ophthalmology 2002; 109: 914-919.